Sartorius Stedim Biotech (SSB), a leading global supplier to the biopharmaceutical industry, recently launched the innovative BIOSTAT® RM TX. This single-use bioreactor system has been specially developed for closed, automated expansion of cell products in a consistent quality, which would make it ideal for applications such as ex vivo cellular immunotherapies. According to SSB, this new ‘good manufacturing practice’ (GMP) platform perfectly blends its trusted Flexsafe® bag technology with its biopharmaceutical automation know-how.
"Combining single-use technology with advanced automation for the expansion of cell products ensures process variability can be controlled and turns safe, robust and affordable cell production into a reality," explains Dr. Franziska Faulstich, Global Product Manager for Regenerative Medicine and RM Bioreactors at Sartorius Stedim Biotech. Pointing out the great benefits this new single-use bioreactor offers to users, she adds: "We collaborated closely with leading cellular immunotherapy companies to identify the right technologies and best-practice workflows before incorporating them into our new BIOSTAT® RM TX bioreactor."
Sartorius Lab Instruments GmbH & Co. KG (37079 Göttingen, Germany)